INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Showing studies that examined mushrooms. Clear

10 studies

2021 / Prospective cohort study and meta-analysis of prospective cohort studies

In a meta-analysis of prospective cohort studies, mushroom intake was linked to a lower risk of all-cause mortality.

Researchers analyzed 30,378 NHANES participants over a mean follow-up of 6.7 years and conducted a meta-analysis combining these data with four other prospective cohort studies (totaling 601,893 individuals). In NHANES, mushroom consumption showed a non-significant association with all-cause mortality after multivariable adjustments (adjusted HR 0.84; 95% CI: 0.67-1.06; 2,855 deaths). However, the meta-analysis found that mushroom consumption was associated with a lower risk of all-cause mortality (pooled risk ratio 0.94; 95% CI: 0.91, 0.98).

Shows an association, not proof of cause and effect.

Ba DM, Gao X, Al-Shaar L, et al. Nutr J, 2021. PMID 34548082

2020 / Pilot double-blind randomized placebo-controlled trial

Erinacine A-enriched Hericium erinaceus mycelia capsules for 49 weeks improved cognitive scores and contrast sensitivity in patients with mild Alzheimer's disease.

Patients with mild Alzheimer's disease were randomized to receive three 350 mg erinacine A-enriched Hericium erinaceus mycelia (EAHE) capsules per day (5 mg/g erinacine A) or placebo for 49 weeks following a 3-week screening period. After 49 weeks, the EAHE group showed significant improvement in MMSE score, a significant difference in IADL score compared to placebo, and a significant decrease in CASI score was noted only in the placebo group. The EAHE group also achieved significantly better contrast sensitivity and showed differences in biomarkers and neuroimaging ADC values compared to placebo. Four subjects dropped out due to abdominal discomfort, nausea, and skin rash, with no other adverse events reported.

Li IC, Chang HH, Lin CH, et al. Front Aging Neurosci, 2020. PMID 32581767

2020 / Randomized, double-blinded, placebo-controlled clinical trial

Supplementation with vitamin D3 or vitamin D-enriched mushrooms showed no significant effect on cognitive function or mood in healthy older adults.

A 6-month trial examined the effects of vitamin D3, enhanced vitamin D2 in a mushroom matrix, standard mushroom, and placebo in 436 healthy adults aged ≥60 years. Total 25-OH-D and 25-OH-D3 levels were maintained in the vitamin D3 arm but decreased significantly (p < 0.05) in the other three arms. There were no significant effects of treatment on any measures of cognitive function or mood over 24 weeks.

Zajac IT, Barnes M, Cavuoto P, et al. Nutrients, 2020. PMID 33339304

2019 / Randomized, double-blind, placebo-controlled parallel-group comparative study

Oral intake of Hericium erinaceus supplements for 12 weeks significantly improved MMSE cognitive function scores.

A randomized, double-blind, placebo-controlled parallel-group comparative study evaluated the effect of Hericium erinaceus fruiting body supplements taken for 12 weeks on cognitive functions. Cognitive performance was assessed using the Mini Mental State Examination (MMSE), Benton visual retention test, and Standard verbal paired-associate learning test (S-PA). MMSE alone showed that oral intake of H. erinaceus significantly improved cognitive functions and prevented deterioration.

Saitsu Y, Nishide A, Kikushima K, et al. Biomed Res, 2019. PMID 31413233

2009 / Double-blind, parallel-group, placebo-controlled randomized trial

Yamabushitake (Hericium erinaceus) supplementation significantly improved cognitive function scores in adults with mild cognitive impairment.

Thirty Japanese men and women aged 50 to 80 with mild cognitive impairment were randomized to take either Yamabushitake (four 250 mg tablets containing 96% dry powder three times daily) or placebo for 16 weeks, followed by 4 weeks of observation. At weeks 8, 12, and 16, the Yamabushitake group showed significantly increased cognitive function scale scores compared with placebo, with scores increasing with duration of intake. However, scores decreased significantly by 4 weeks after terminating intake. Laboratory tests showed no adverse effects.

Mori K, Inatomi S, Ouchi K, et al. Phytother Res, 2009. PMID 18844328

2022 / Cross-sectional analysis of NHANES survey data

Higher mushroom intake was linked to better performance on certain cognitive tests in US older adults.

Data from 2,840 older adults aged ≥ 60 years from NHANES 2011-2014 were analyzed to evaluate the link between mushroom consumption (via up to two 24-h recalls) and cognitive performance tests. Compared with the lowest intake category, participants in the highest category (median intake = 13.4 g/1000 kcal/d) scored higher on the DSST (β = 3.87; 95% CI 0.30, 7.45; P for trend = 0.03) and CERAD-WL (β = 1.05; 95% CI 0.0003, 2.10; P for trend = 0.04). Non-significant associations were observed for the Animal Fluency test (β = 0.24; 95% CI -2.26, 2.73; P for trend = 0.92) and no association was found for CERAD-DR.

Shows an association, not proof of cause and effect.

Ba DM, Gao X, Al-Shaar L, et al. Br J Nutr, 2022. PMID 35115063

2021 / Prospective nested case-control study

Food- and microbiota-derived metabolites, including from mushrooms and coffee, were associated with cognitive decline over a 12-year prospective study.

In two nested case-control sets from the Three-City Cohort (Bordeaux, n = 418; Dijon, n = 424), circulating food-related and microbiota-derived metabolites were analyzed in participants free of dementia at baseline. Cognitive decline was evaluated through five neuropsychological tests over 12 years. A protective association was found between cognitive decline and metabolites derived from cocoa, coffee, mushrooms, red wine, and the microbial metabolism of polyphenol-rich foods, while a negative association was found with metabolites related to artificial sweeteners and alcohol.

Shows an association, not proof of cause and effect.

González-Domínguez R, Castellano-Escuder P, Carmona F, et al. Mol Nutr Food Res, 2021. PMID 34661340

2019 / Community-based cross-sectional study

Consuming more than two portions of mushrooms per week was linked to reduced odds of mild cognitive impairment in older adults.

Researchers analyzed cross-sectional data from 663 participants aged 60 and older from the Diet and Healthy Aging (DaHA) study in Singapore to evaluate the link between mushroom intake and mild cognitive impairment (MCI). Participants who consumed mushrooms more than two portions per week had reduced odds of MCI compared with those consuming them less than once per week (OR = 0.43, 95% CI 0.23-0.78, p = 0.006). This association remained independent of age, gender, education, smoking, alcohol use, medical history, and physical or social activities.

Shows an association, not proof of cause and effect.

Feng L, Cheah IK, Ng MM, et al. J Alzheimers Dis, 2019. PMID 30775990

2017 / Cross-sectional analysis

A 'Plant foods and fish' dietary pattern was linked to higher cognitive function scores among older Japanese adults.

This cross-sectional study evaluated 635 community-dwelling Japanese participants aged 69-71 years to examine the relationship between dietary patterns and cognitive function measured by the MoCA-J. Three dietary patterns were identified: 'Plant foods and fish', 'Rice and miso soup', and 'Animal food'. The 'Plant foods and fish' pattern was significantly associated with a higher MoCA-J score after adjustment for potential confounders (β = 0.41 per one-quartile increase, 95% CI: 0.17 to 0.65, P for trend < 0.001). Neither the 'Rice and miso soup' nor the 'Animal food' pattern was related to cognitive function.

Shows an association, not proof of cause and effect.

Okubo H, Inagaki H, Gondo Y, et al. Nutr J, 2017. PMID 28893250

2010 / Cross-sectional study

Higher intake of plant foods was linked to better cognitive performance in a dose-dependent manner among older adults.

In the Hordaland Health Study, researchers examined the relationship between plant food intake and cognitive performance in 2,031 individuals aged 70-74 years using a validated FFQ and a cognitive test battery. Subjects with intakes above the 10th percentile for fruits, vegetables, grain products, and mushrooms performed significantly better on cognitive tests than those with very low or no intake. Strongest associations were found for combined fruit and vegetable intake up to about 500 g/d, while grain products and potatoes plateaued at 100-150 g/d, and mushroom intake showed a linear association. Among individual foods, positive associations were most pronounced for carrots, cruciferous vegetables, citrus fruits, and high-fibre bread, whereas white bread intake was negatively associated with cognition.

Shows an association, not proof of cause and effect.

Nurk E, Refsum H, Drevon CA, et al. Br J Nutr, 2010. PMID 20550741